Inflammatory signatures in the spectrum of myeloid diseases. [PDF]
Ibbotson A +12 more
europepmc +1 more source
Final analysis of phase 2 clinical trial of ruxolitinib and azacitidine combination therapy in patients with myelodysplastic syndrome/myeloproliferative neoplasms. [PDF]
Arora S +23 more
europepmc +1 more source
Recrudescence of a FLT3 wild-type CMML clone after allogeneic stem cell transplant for FLT3-ITD acute myeloid leukemia. [PDF]
Ellaithy HA +3 more
europepmc +1 more source
Disease states associated with lysozymuria, along with histological correlations. [PDF]
Ziri M +5 more
europepmc +1 more source
Splicing factor mutations clearance and outcomes in clonal myeloid neoplasms: a referral center experience. [PDF]
Tanariyakul M +8 more
europepmc +1 more source
A Reliable Method for Thawing Primary AML and CMML Mononuclear Cells to Preserve Viability and Function. [PDF]
Lim K +5 more
europepmc +1 more source
Connective tissue diseases combined with chronic myelomonocytic leukemia and myelofibrosis: a case report and literature review. [PDF]
Yin HQ, Jin S, Fu Y, Zhu HL, Li XF.
europepmc +1 more source
Longitudinal Changes in Transfusion Practice in Myelodysplastic Syndromes: A Population Data-Linkage Study. [PDF]
Mo A +5 more
europepmc +1 more source
Isolated add(12)(p13) in a BCR::ABL1-Negative Neutrophilic Myeloproliferative Neoplasm Lacking Canonical Driver Mutations: A Case Report. [PDF]
Dhaka M +4 more
europepmc +1 more source
Impact of concurrent autoimmune conditions on clinical outcomes and leukaemic transformation in chronic myelomonocytic leukaemia. [PDF]
Rungjirajittranon T +3 more
europepmc +1 more source

